(210) | Number of the EPO application | 16862773 |
(220) | Filing date of the EPO application | 2016.11.01 |
(80) | EPO patent specification publication (B) | EPB nr. 02/2022, 2022.01.12 |
(110) | EPO patent number | 3370768 |
(11) | Number of the document | MD 3370768 T2 |
(21) | Number of the application | e 2018 0896 |
(71) | Name(s) of applicant(s), code of the country | JANSSEN BIOTECH INC., US; |
(72) | Name(s) of inventor(s), code of the country | VERONA Raluca, US; POWERS Gordon, US; SABINS Nina Chi, US; DEANGELIS Nikki A., US; SANTULLI-MAROTTO Sandra, US; WIEHAGEN Karla R., US; WU Sheng-Jiun, US; FERRANTE Catherine, US; UBANI Enrique-Zudaire, US; |
(73) | Name(s) of owner(s), code of the country | JANSSEN BIOTECH INC., US; |
(54) | Title of the invention | Antibodies specifically binding pd-1 and their uses |
(13) | Kind-of-document code | T2 |
(51) | International Patent Classification | A61K 39/395 (2006.01.01); C12N 15/13 (2006.01.01); C07K 16/18 (2006.01.01); A61P 35/00 (2006.01.01); C07K 16/28 (2006.01.01) |
(19) | Country | US |
(41) | Date of publication of the application | 2018.10.31 |
(49) | Date of publication of the translation of the validated European patent specification | 2022.07.31 |
(30) | Priority | 201562250095 P, 2015.11.03, US |
(74) | Patent attorney | (Procedură) PARASCA Dumitru, str. Eminescu nr. 40, ap. 13, c/p 28, MD-2012, Chişinău, Republica Moldova |
(86) | International application | PCT/US2016/059833, 2016.11.01 |
(87) | International publication | WO 2017/079112, 2017.05.11 |